您当前的位置：
首页 >
文章列表页 >
Clinical decision on surgical resection for patients with complete response after conversion therapy for hepatocellular carcinoma： controversy and consensus
更新时间：2026-11-05

    • Clinical decision on surgical resection for patients with complete response after conversion therapy for hepatocellular carcinoma： controversy and consensus

    • J Abdominal Surg   Vol. 38, Issue 5, Pages: 340-345(2025)

    • DOI：10.3969/j.issn.1003-5591.2025.05.002    

      CLC： R735.7

    • Published：22 October 2025

    移动端阅览

  • Luo Xuan,Chen Yajin.Clinical decision on surgical resection for patients with complete response after conversion therapy for hepatocellular carcinoma： controversy and consensus[J].J Abdominal Surg,2025,38(05):340-345. DOI： 10.3969/j.issn.1003-5591.2025.05.002.

  •  
  •  

0

Views

2

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Current status and perspectives on conversion therapy for hepatocellular carcinoma in the era of targeted immunotherapy
Current status and analysis of combined therapy based on the hepatic arterial infusion chemotherapy for middle-stage and advanced hepatocellular carcinoma
Several outstanding issues for conversion therapy of liver cancer
Efficacy analysis of subsegmental ablation for hepatocellular carcinoma based on the portal venous territory
Current status and advances in imaging in the full-course management of local therapy for hepatocellular carcinoma

Related Author

Cai Changchun
Li Xin
Wang Zhengwen
Pan Caiyan
Wang Xianzheng
Xu Shengjiang
Yuan Yufeng
Zhang Zhonglin

Related Institution

Ward I， Department of Hepatic-Biliary-Pancreatic Surgery， the Central Hospital of Wuhan， Tongji Medical College， Huazhong University of Science and Technology
The First Clinical College of Hainan Medical University
Department of Hepatobiliary and Pancreatic Surgery，Hainan Cancer Hospital（The Affiliated Cancer Hospital of Hainan Medical University）；Hainan Clinical Medical Research Center of Liver Disease and Liver Critical Illness
Department of Hepatobiliary & Pancreatic Surgery， Zhongnan Hospital of Wuhan University，Hubei Wuhan430071， China； Clinical Medicine Research Center for Mini-Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province
Department of Hepatobiliary Surgery， the First Affiliated Hospital of Army Medical University （Southwest Hospital）
0